GRAIL, Inc. is an American biotechnology company based in Menlo Park, California. It was previously a subsidiary of Illumina started as a startup seeking to develop an early cancer screening test for
people who do not have symptoms. Grail was spun-out from Illumina on June 24, 2024.
